News | Artificial Intelligence | December 07, 2021

Study results demonstrate the accuracy of AI-based ultrasound software, enabling a quicker detection of right ventricle dysfunction caused by COVID-19, pulmonary embolism, and more

DiA Imaging Analysis, a leading provider of advanced AI-based software for ultrasound analysis, was featured in a recent study presented by a team of cardiac physicians from Mount Sinai's Icahn School of Medicine at the American Heart Association meeting.

December 7, 2021 — DiA Imaging Analysis, a leading provider of advanced AI-based software for ultrasound analysis, was featured in a recent study presented by a team of cardiac physicians from Mount Sinai's Icahn School of Medicine at the American Heart Association meeting. The breakthrough study demonstrated the accuracy of LVivo RV, the company's AI for right ventricle function analysis, validating its sensitivity and specificity results compared to Cardiac MRI (CMR).

Right Ventricle (RV) size and function are vital indicators of cardiac dysfunction, including pulmonary embolism (PE), pulmonary hypertension, and right heart failure. Amid the COVID-19 pandemic, cardiac ultrasound imaging includes assessment of the RV to detect RV dysfunction, commonly seen in patients with COVID-19. Although common, RV function analysis using an ultrasound device is difficult and often requires additional examination due to the RV's challenging geometry. 

The recent study of 125 patients compared DiA's right heart AI-based software to CMR. Results demonstrated high sensitivity and specificity when compared to CMR, the gold standard of cardiac imaging. The study concluded that DiA's automated AI-based right heart analysis for automated RV function quantification has the potential to accurately and instantly detect evidence of right heart dysfunction at the echo lab and near the bedside.

Dr. Martin Goldman, professor of cardiology at Mount Sinai and a leading author of the study said, "As echo is the first imaging triage modality used for scanning suspected heart issues, this study validated the potential of adding AI as part of our cardiac ultrasound workflow." 

"We are proud to share that leading physicians from the Icahn School of Medicine at Mount Sinai, a globally ranked program, have validated our FDA-approved AI software," said Hila Goldman-Aslan, CEO and co-founder of DiA Imaging Analysis. "The study demonstrated that LVivo RV can provide an automated and accurate solution to the critical analysis of the right ventricle function using ultrasound." 

The study, Validation of Artificial Intelligence for Assessing Right Ventricular Function by Transthoracic Echocardiography, was conducted by Brian Hsia, Ashton Lai, Rajeev Samtani, Solomon Bienstock, Steve Liao, Eric Stern, Gina LaRocca, Javier Sanz, Stamatios Lerakis, Gregg W Stone, Lori Croft, and Martin Goldman, of the Icahn School of Medicine at Mount Sinai, New York, NY. The results were presented to the American Heart Association on November 15, 2021. The study was published in Circulation Magazine, Volume 144, Issue 1.

For more information: www.dia-analysis.com/

Related RSNA2021 content


Related Content

News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise[1] MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

July 1, 2025 — UPDATE: The final paper is now available at: JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics ...

Time July 01, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Image Guided Radiation Therapy (IGRT)

June 25, 2025 — Royal Philips and Indiana-based Methodist Hospitals recently announced the healthcare provider’s ...

Time June 25, 2025
arrow
News | PET-CT

June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging ...

Time June 23, 2025
arrow
News | Bone Densitometry Systems

June 19, 2025 — Naitive Technologies has published results demonstrating the diagnostic performance of its AI-powered ...

Time June 18, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Digital Pathology

June 11, 2025 — Diagnostic laboratory leaders view digital pathology and artificial intelligence (AI) as pivotal to ...

Time June 12, 2025
arrow
News | Lung Imaging

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global ...

Time June 11, 2025
arrow
Subscribe Now